Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Understanding Early and Late Endpoints in Registrational Trials of Community-acquired Bacterial Pneumonia.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 07, 2020
Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 19, 2019
Widening the Overton Window-While Avoiding Defenestration.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 18, 2019
Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.
Journal: The New England journal of medicine
Published: February 21, 2019
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 13, 2018
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 12, 2018
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 29, 2018
Evolution and current status of United States Food and Drug Administration and European Medicines Agency regulatory guidance for studies of nosocomial pneumonia.
Journal: Current opinion in critical care
Published: August 30, 2018
Clostridium difficile Infection-Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds.
Journal: Health and quality of life outcomes
Published: August 22, 2018
Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.
Journal: The Lancet. Infectious diseases
Published: May 18, 2018
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Journal: The Journal of infectious diseases
Published: April 04, 2018
The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: February 09, 2017
Last Updated: 09/26/2026